Murray M, Wilkinson C F, Dubé C E
Toxicol Appl Pharmacol. 1983 Mar 30;68(1):66-76. doi: 10.1016/0041-008x(83)90355-1.
Changes in cytochromes P-450, aminopyrine N-demethylase (APDM), aromatic hydrocarbon (benzo[a]pyrene) hydroxylase (AHH), and type III spectral complex formation were measured in hepatic microsomes of control, phenobarbital (PB)-, and beta-naphthoflavone (beta NF)-induced rats after a single dose of dihydrosafrole (4-n-propyl-1,2-methylenedioxybenzene, DHS). Time profiles of changes in these microsomal parameters were complex and showed that APDM activities and cytochrome P-450 levels decreased immediately after treatment and were associated with concurrent increases in the intensity of the type III methylenedioxyphenyl (MDP) metabolite/cytochrome P-450 spectral complex. In noninduced rats, both APDM activity and cytochrome P-450 levels returned to control levels between 12 and 24 hr after treatment with DHS and subsequently increased above control levels. In PB- and beta NF-induced animals, the inhibitory phases were more prolonged and activity never returned to levels higher than the corresponding controls. AHH activity was increased substantially (two- to three-fold) in all cases after DHS administration. Although displacement of the MDP metabolite/cytochrome P-450 complex with 2-methylbenzimidazole generally led to a marked restoration of cytochrome P-450 levels and partially reversed the inhibition of APDM, it had little or no effect on AHH activities.
在给予单剂量二氢黄樟素(4 - 正丙基 - 1,2 - 亚甲二氧基苯,DHS)后,测定对照、苯巴比妥(PB)和β - 萘黄酮(βNF)诱导的大鼠肝微粒体中细胞色素P - 450、氨基比林N - 脱甲基酶(APDM)、芳烃(苯并[a]芘)羟化酶(AHH)的变化以及III型光谱复合物的形成。这些微粒体参数的变化时间曲线很复杂,表明治疗后APDM活性和细胞色素P - 450水平立即下降,并与III型亚甲二氧基苯基(MDP)代谢物/细胞色素P - 450光谱复合物强度的同时增加有关。在未诱导的大鼠中,用DHS治疗后12至24小时内,APDM活性和细胞色素P - 450水平恢复到对照水平,随后高于对照水平。在PB和βNF诱导的动物中,抑制期更长,活性从未恢复到高于相应对照的水平。给予DHS后,所有情况下AHH活性均大幅增加(两到三倍)。尽管用2 - 甲基苯并咪唑取代MDP代谢物/细胞色素P - 450复合物通常会导致细胞色素P - 450水平显著恢复,并部分逆转对APDM的抑制,但对AHH活性几乎没有影响。